A US Senate panel is considering legislation that would expand the array of subject matter that is eligible to be patented.
A draft bill provides for a major expansion of eligible material, a move the ACLU and AMP said threatens to reduce competition in genetic testing.
The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.
The firm's CEO Kevin Ness said confirmation of MAD7's editing activity in human HEK293T cells shows the potential for Inscripta's technology.
A new analysis finds that one company filed most of the patents on genes from deep-sea organisms, the Independent reports.
A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.
In February, the USPTO's Patent Trial and Appeal Board stopped UC's bid for IP underpinning the most lucrative applications of genome editing.
The plaintiffs say the USPTO made several errors when it determined the Broad Institute had the right to patent the use of CRISPR/Cas9 in eukaryotes.
Two Australian organizations are appealing a patent covering much of the cattle genome, according to ABC.
Arti Rai and Colleen Chien are studying whether the Supreme Court's decisions in Mayo v Prometheus and Bilski v Kappos have had a negative impact on diagnostics innovation.
GenomeWeb reports that Veritas Genetics is suspending its US operations.
A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.
Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.
In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.